SEC Comment Letter for METLIFE (MET) — Jan 19, 2018

METLIFE INC
Date: Jan. 19, 2018 · CIK: 0001099219 · Accession: 0000000000-18-002006

View on Edgar

AI Filing Summary & Sentiment

Date

January 19, 2018

Author

Not clearly detected

Form

UPLOAD

Company

METLIFE INC

Letter

January 19, 2018 John C. R. Hele Executive Vice President and Chief Financial Officer MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 Metlife, Inc. Form 10-Q for the Quarterly Period Ended September 30, 2017 Filed November 6, 2017 File No. 001-15787Re: Dear Mr. Hele: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

January 19, 2018
John C. R.  Hele
Executive Vice President and Chief Financial Officer
MetLife, Inc.
200 Park Avenue
New York, NY 10166-0188
Metlife, Inc.
Form 10-Q for the Quarterly Period Ended September 30, 2017
Filed November 6, 2017
File No. 001-15787Re:
Dear Mr. Hele:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io